Banking and brokerage firm Laidlaw and Company finds itself in trouble with the law after some of its clients filed law lawsuits in court against the company. The company, which was founded in 1999, is a full-service investment banking firm. The corporation offers personalized advice and execution guidance to its clients, most of whom include private institutions, public businesses, and individual investors.
The firm conducts over ten types of businesses, key among them being the buying and selling of securities on behalf of its clients. Laidlaw & Company is affiliated with several other financial and investment firms. Among the organizations that the corporation is registered with are the SEC and 1 Self-Regulatory Org.
Recently, some of Laidlaw’s customers filed cases in court accusing the firm of serious corruption and defamation. One client, Remalda Therapeutics, lodged a complaint with the U.S. District Court for the District of Nevada on September 14th, 2016 accusing the brokerage firm of several charges. Remalda Therapeutics are suing Laidlaw and Company for defamation/business and defamation per se. The complainant, who deal with the development of innovative therapies for the treatment of diseases affecting the central nervous system, also accuse the Defendants of tortious interference by the investment firm with the intention to gain financial advantage.
Some of the names mentioned in the corruption scandals dogging Laidlaw & Company are Mathew Eitner and James Ahern. Remalda accuses the two principals of disseminating false proxy materials to the complainant. Eitner and Ahern, according to Remalda, providing misguiding information that made the therapeutics firm suffer damage. The clinic wants the court to force Laidlaw and company to compensate these losses and prevent the brokerage firm from harming them in the future. For the brokerage firm and its executives, the bad publicity caused by these scandals could prove very disastrous.
References
http://www.relmada.com/news-events/press-releases/detail/161/relmada-therapeutics-files-amended-complaint-against

Relmada Seeks Payback for Damage Done By Laidlaw